Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Pioneer in the Field of Reproductive Medicine Recognized for Lifetime Achievement


News provided by

Olive Fertility Centre

Sep 29, 2022, 06:00 ET

Share this article

Share toX

Share this article

Share toX


Known as the grandfather of IVF in Canada, Olive Fertility Centre co-founder and co-director Dr. Albert Yuzpe receives prestigious award for contribution to fertility treatment.

VANCOUVER, Canada, Sep. 29, 2022 /PRNewswire-PRWeb/ -- Olive Fertility Centre is proud to announce that Dr. Al Yuzpe, co-director and co-founder of Olive Fertility Centre, Chief Medical Officer for The Fertility Partners, and a pioneer in reproductive medicine, received the 2022 Lifetime Achievement Award at the 68th Canadian Fertility and Andrology Society (CFAS) Annual Meeting.

The Lifetime Achievement Award is a special recognition of an individual for extraordinary commitment and proven long-term contributions to the nonprofit CFAS and the field of reproductive science.

Dr. Yuzpe has been a shoulder to stand on, a mentor, and an inspiration to so many of us in the field of fertility,” says Dr. Hitkari, co-director and co-founder of Olive Fertility Centre

Post this

It would be difficult to overstate the impact that Dr. Yuzpe has had on the lives of thousands of individuals and couples in British Columbia, Canada and worldwide. He has been called the "grandfather of IVF in Canada" and is the recipient of numerous awards for his distinguished career in reproductive endocrinology and infertility and his dedication to women's health. During his over 50-year career Dr Yuzpe has been internationally recognized for his pioneering work and has helped untold numbers of infertile couples realize their dream of having a family.

"And beyond his contribution to the advancement of fertility treatment and women's health, Dr. Yuzpe has been a shoulder to stand on, a mentor, and an inspiration to so many of us in the field of fertility, not to mention a compassionate and beloved doctor to the thousands of individuals and couples he has helped to create a family," says Dr. Jason Hitkari, co-director and co-founder of Olive Fertility Centre.

Dr. Yuzpe has contributed to many ground-breaking advancements that are not only the cornerstones of modern fertility treatment but have helped save the lives and improve the health of millions of women. Dr. Yuzpe is responsible for the development of an emergency contraceptive method using regularly available birth control pills, also referred to as the "Yuzpe method."
He is renowned for his contribution to the development of laparoscopic surgery. During the 1970s and 1980s, Dr. Yuzpe helped to develop and refine the method by which surgeries could be done through small "keyhole" incisions, thereby reducing pain and recovery times for patients. The field of laparoscopy has now revolutionized medicine in Canada and internationally as minimally invasive surgery has become the norm in virtually every surgical specialty from fertility treatment to gynecology, to orthopedics, to general surgery.

Dr. Yuzpe is a leader in fertility treatment in Canada. When he first began his career there was little that medicine could offer infertile couples. Dr. Yuzpe has been instrumental in developing the cornerstone treatments and protocols which are now the standard for fertility treatment worldwide, including developing the fertility drugs, clomiphene citrate and human menopausal gonadotropins.

Early on, he recognized how in vitro fertilization (IVF) could revolutionize the treatment of infertility and how it had the potential to help millions of couples struggling to have a family. Because of his work with the Nobel Prize-winning scientists Dr. Robert Steptoe and Dr. Patrick Edwards, the U.K. physicians responsible for the world's first IVF birth in 1978, Dr. Yuzpe was instrumental in bringing IVF to Canada, and in 1982 he founded one of the first IVF centers in Canada at the University of Western Ontario.

"Over the past few years, I have had the opportunity to develop a strong relationship with Dr. Al Yuzpe," said CFAS Executive Director Dr. Goldi Gill. "Reflective of his knowledgeable and humble character, he is always willing to lend a helping hand to both me and the CFAS, an organization he has been an integral part of for so many years. I am thrilled that he is receiving this prestigious award, as it demonstrates his dedication to the CFAS, as well as the greater field of assisted reproductive technology (ART)."

"When I first began my career in obstetrics and gynecology in the 1970s, we didn't have very much to offer those who suffered from infertility," said Dr. Yuzpe. "Now there is so much we can do. I feel fortunate to have worked with so many great minds over the years and to have been a part of the growth of fertility medicine. Thank you CFAS for the honor. Together, we have achieved great things."

Not only has Dr Yuzpe been a visionary in the field of infertility, he has led the way in making family building accessible to all. At a time when fertility treatment was only available to married couples in British Columbia, Dr. Yuzpe and co-founder Dr. Margo Fluker opened a clinic that they envisioned would be available to anyone who wished to create a family.

"When the original clinic we were part of was born in 1995, Al and his working partner vowed to make the clinic all-inclusive, in other words, welcoming and accessible to all those wanting to create a family, regardless of their gender, sexuality, and relationship status," says Wendy Baker RN, Coordinator Donor Sperm Program, Olive Fertility.

"We have always held tremendous respect for Dr. Yuzpe's decades of experience and tireless commitment to improving fertility medicine," said Dr. Andrew Meikle, Founder and Chief Executive Officer of The Fertility Partners (TFP). "The CFAS Lifelong Achievement Award is a great honor and well deserved. I know the entire TFP network is beyond proud to consider him part of the team."

Olive Fertility Centre olivefertility.com is one Canada's leading fertility and prenatal diagnosis clinics, offering an award-winning IVF lab, personal care teams, and innovative programs including specialized genetic testing, egg freezing and prenatal NIPT testing.

Media Contact

Mairi Campbell, Olive Fertility Centre, 1 778-885-5300, [email protected]

SOURCE Olive Fertility Centre

Modal title

Dr Yuzpe Receives CFAS Lifetime Achievement Award
Dr Yuzpe Receives CFAS Lifetime Achievement Award
Dr Yuzpe with CFAS Lifetime Achievement Award
Dr Yuzpe with CFAS Lifetime Achievement Award
Dr Yuzpe Receives CFAS Lifetime Achievement Award Dr Yuzpe with CFAS Lifetime Achievement Award

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.